Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4346989 | 0.89 | ALDH1A1 (0.32) | KDM4EALDH1A1MAPT | |
| SCHEMBL534610 | 0.77 | KDM4E (0.58) | KDM4EALDH1A1MAPTPKMPOLB | |
| SCHEMBL4333767 | 0.76 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL11451438 | 0.71 | EPHX1 (0.46) | EPHX1 | |
| SCHEMBL10171551 | 0.67 | EPHX1 (0.33) | KDM4EGAAEPHX1 | |
| SCHEMBL9147847 | 0.67 | EPHX1 (0.32) | KDM4EALDH1A1EPHX1 | |
| SCHEMBL16399256 | 0.65 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL9213215 | 0.64 | EPHX1 (0.34) | ALDH1A1EPHX1 | |
| SCHEMBL243842 | 0.62 | — | — | |
| SCHEMBL10938600 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090274947-A1 | Imidazolidinone nitroxides as electrode materials for energy storage devices | CIBA CORP. | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274947-A1 | Imidazolidinone nitroxides as electrode materials for energy storage devices | IDH2, NQO1, NOX1 | KDM4E 253/4885ALDH1A1 1206/4885MAPT 4084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.